Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
435.50    -0.50 (-0.11%)
Bid:
432.00
Ask:
435.50
Spread: 3.50 (0.81%)
Market Cap: £151.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

EBT and Directors' Dealings

11 Mar 2015 16:29

RNS Number : 2108H
Frontier Developments PLC
11 March 2015
 

11 March 2015

Frontier Developments plc

(the "Company")

 

EBT and Directors' Dealings

 

Frontier Developments plc (AIM: FDEV, "Frontier", the "Group"), a leading developer of video games, announces the following dealings:

 

Employee Benefit Trust Dealings

 

The Company was notified today by Appleby Trust (Jersey) Limited, the trustee of the Frontier Developments plc Employee Share Ownership Plan Trust (the "EBT"), that the EBT transferred 121,000 ordinary shares of 0.5p each in the Company ("Ordinary Shares") to certain of the Company's employees on 11 March 2015 in order to satisfy the exercise of share options. These options had an average exercise price of 74 pence per Ordinary Share. The EBT also purchased 29,534 Ordinary Shares at 230 pence per Ordinary Share on 11 March 2015.

 

Following this transaction, the EBT is interested in 59,965 Ordinary Shares, representing 0.2 per cent of the Company's total issued share capital.

 

The EBT is a discretionary trust for the benefit of employees of the Company and its subsidiaries, who have been granted share options. The Executive Directors of the Company are included in the class of potential beneficiaries of the EBT and are deemed to be interested in those shares and the dealings thereof.

 

Directors' Dealings

 

As part of the dealings referred to above, Jonathan Watts, Chief Creative Officer has today exercised share options in respect of 30,000 Ordinary Shares at an exercise price of 67 pence per Ordinary Share.

 

Neil Armstrong, Chief Financial Officer (an applicable employee under the AIM Rules) has today exercised share options in respect of 12,500Ordinary Shares at an exercise price of 89 pence per Ordinary Share.

 

Following the exercise of these options, Mr. Watts and Mr. Armstrong today sold 8,740 Ordinary Shares and 4,837 Ordinary Shares respectively at a price of 230p per Ordinary Share to meet the exercise costs and associated tax liabilities.

 

Following these option exercises and related sales, the interests of Mr. Watts and Mr. Armstrong are as follows:

 

 Director

Number of Ordinary Shares prior to transactions

Number of Ordinary Shares following transactions

Total resulting interest in Ordinary Shares as % of issued share capital

Jonathan Watts

23,500

44,760

0.1%

Neil Armstrong

18,500

26,163

0.1%

 

Enquiries:

 

Frontier Developments

+44 (0)1223 394 300

 

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

 

 

 

 

 

 

Canaccord Genuity

+44 (0) 207 523 8000

 

Simon Bridges/Cameron Duncan

 

 

 

 

 

 

Finncap

+44 (0) 207 220 0506

 

Charlotte Stranner

 

 

 

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

 

James Macey White

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNSFWFMFFISEED
Date   Source Headline
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.